- 09:00 – 10:10
Plenary Hall (Ballsaal)
Chairs: Chiara Bonini, Vita-Salute San Raffaele University, Italy
Michael Hudecek, LETSimmun Consortium, Germany
14:10 – 14:35
KEYNOTE LECTURE: CONQUERING RESISTANCE MECHANISMS IN ENGINEERED CELL THERAPIES
Stanley Riddell, Fred Hutchinson Cancer Research Center, USA
14:35 -14:50
RWE: BEYOND CRS AND ICANS: HEMATOTOXICITY AND INFECTIONS AS DRIVERS OF CAR-T NRM
Marion Subklewe, LETSimmun Consortium, Germany
14:50 – 15:05
CLINICAL LEARNINGS AND NEW FRONTIERS FOR B CELL-DRIVEN DISEASES
Jennifer Brogdon, Novartis, USA
15:05 – 15:45
Panel discussion
- 09:00 – 10:10
Plenary Hall (Ballsaal)
Chairs: Chiara Bonini, Vita-Salute San Raffaele University, Italy
Michael Hudecek, LETSimmun Consortium, Germany
14:10 – 14:35
KEYNOTE LECTURE: CONQUERING RESISTANCE MECHANISMS IN ENGINEERED CELL THERAPIES
Stanley Riddell, Fred Hutchinson Cancer Research Center, USA
14:35 -14:50
RWE: BEYOND CRS AND ICANS: HEMATOTOXICITY AND INFECTIONS AS DRIVERS OF CAR-T NRM
Marion Subklewe, LETSimmun Consortium, Germany
14:50 – 15:05
CLINICAL LEARNINGS AND NEW FRONTIERS FOR B CELL-DRIVEN DISEASES
Jennifer Brogdon, Novartis, USA
15:05 – 15:45
Panel discussion
- 09:00 – 10:10
Plenary Hall (Ballsaal)
Chairs: Chiara Bonini, Vita-Salute San Raffaele University, Italy
Michael Hudecek, LETSimmun Consortium, Germany
14:10 – 14:35
KEYNOTE LECTURE: CONQUERING RESISTANCE MECHANISMS IN ENGINEERED CELL THERAPIES
Stanley Riddell, Fred Hutchinson Cancer Research Center, USA
14:35 -14:50
RWE: BEYOND CRS AND ICANS: HEMATOTOXICITY AND INFECTIONS AS DRIVERS OF CAR-T NRM
Marion Subklewe, LETSimmun Consortium, Germany
14:50 – 15:05
CLINICAL LEARNINGS AND NEW FRONTIERS FOR B CELL-DRIVEN DISEASES
Jennifer Brogdon, Novartis, USA
15:05 – 15:45
Panel discussion
- 09:00 – 10:10
Plenary Hall (Ballsaal)
Chairs: Chiara Bonini, Vita-Salute San Raffaele University, Italy
Michael Hudecek, LETSimmun Consortium, Germany
14:10 – 14:35
KEYNOTE LECTURE: CONQUERING RESISTANCE MECHANISMS IN ENGINEERED CELL THERAPIES
Stanley Riddell, Fred Hutchinson Cancer Research Center, USA
14:35 -14:50
RWE: BEYOND CRS AND ICANS: HEMATOTOXICITY AND INFECTIONS AS DRIVERS OF CAR-T NRM
Marion Subklewe, LETSimmun Consortium, Germany
14:50 – 15:05
CLINICAL LEARNINGS AND NEW FRONTIERS FOR B CELL-DRIVEN DISEASES
Jennifer Brogdon, Novartis, USA
15:05 – 15:45
Panel discussion
- 09:00 – 10:10
Plenary Hall (Ballsaal)
Chairs: Chiara Bonini, Vita-Salute San Raffaele University, Italy
Michael Hudecek, LETSimmun Consortium, Germany
14:10 – 14:35
KEYNOTE LECTURE: CONQUERING RESISTANCE MECHANISMS IN ENGINEERED CELL THERAPIES
Stanley Riddell, Fred Hutchinson Cancer Research Center, USA
14:35 -14:50
RWE: BEYOND CRS AND ICANS: HEMATOTOXICITY AND INFECTIONS AS DRIVERS OF CAR-T NRM
Marion Subklewe, LETSimmun Consortium, Germany
14:50 – 15:05
CLINICAL LEARNINGS AND NEW FRONTIERS FOR B CELL-DRIVEN DISEASES
Jennifer Brogdon, Novartis, USA
15:05 – 15:45
Panel discussion
- 09:00 – 10:10
Plenary Hall (Ballsaal)
Chairs: Chiara Bonini, Vita-Salute San Raffaele University, Italy
Michael Hudecek, LETSimmun Consortium, Germany
14:10 – 14:35
KEYNOTE LECTURE: CONQUERING RESISTANCE MECHANISMS IN ENGINEERED CELL THERAPIES
Stanley Riddell, Fred Hutchinson Cancer Research Center, USA
14:35 -14:50
RWE: BEYOND CRS AND ICANS: HEMATOTOXICITY AND INFECTIONS AS DRIVERS OF CAR-T NRM
Marion Subklewe, LETSimmun Consortium, Germany
14:50 – 15:05
CLINICAL LEARNINGS AND NEW FRONTIERS FOR B CELL-DRIVEN DISEASES
Jennifer Brogdon, Novartis, USA
15:05 – 15:45
Panel discussion
- 09:00 – 10:10
Plenary Hall (Ballsaal)
Chairs: Chiara Bonini, Vita-Salute San Raffaele University, Italy
Michael Hudecek, LETSimmun Consortium, Germany
14:10 – 14:35
KEYNOTE LECTURE: CONQUERING RESISTANCE MECHANISMS IN ENGINEERED CELL THERAPIES
Stanley Riddell, Fred Hutchinson Cancer Research Center, USA
14:35 -14:50
RWE: BEYOND CRS AND ICANS: HEMATOTOXICITY AND INFECTIONS AS DRIVERS OF CAR-T NRM
Marion Subklewe, LETSimmun Consortium, Germany
14:50 – 15:05
CLINICAL LEARNINGS AND NEW FRONTIERS FOR B CELL-DRIVEN DISEASES
Jennifer Brogdon, Novartis, USA
15:05 – 15:45
Panel discussion
- 09:00 – 10:10
Plenary Hall (Ballsaal)
Chairs: Chiara Bonini, Vita-Salute San Raffaele University, Italy
Michael Hudecek, LETSimmun Consortium, Germany
14:10 – 14:35
KEYNOTE LECTURE: CONQUERING RESISTANCE MECHANISMS IN ENGINEERED CELL THERAPIES
Stanley Riddell, Fred Hutchinson Cancer Research Center, USA
14:35 -14:50
RWE: BEYOND CRS AND ICANS: HEMATOTOXICITY AND INFECTIONS AS DRIVERS OF CAR-T NRM
Marion Subklewe, LETSimmun Consortium, Germany
14:50 – 15:05
CLINICAL LEARNINGS AND NEW FRONTIERS FOR B CELL-DRIVEN DISEASES
Jennifer Brogdon, Novartis, USA
15:05 – 15:45
Panel discussion
- 09:00 – 10:10
Plenary Hall (Ballsaal)
Chairs: Chiara Bonini, Vita-Salute San Raffaele University, Italy
Michael Hudecek, LETSimmun Consortium, Germany
14:10 – 14:35
KEYNOTE LECTURE: CONQUERING RESISTANCE MECHANISMS IN ENGINEERED CELL THERAPIES
Stanley Riddell, Fred Hutchinson Cancer Research Center, USA
14:35 -14:50
RWE: BEYOND CRS AND ICANS: HEMATOTOXICITY AND INFECTIONS AS DRIVERS OF CAR-T NRM
Marion Subklewe, LETSimmun Consortium, Germany
14:50 – 15:05
CLINICAL LEARNINGS AND NEW FRONTIERS FOR B CELL-DRIVEN DISEASES
Jennifer Brogdon, Novartis, USA
15:05 – 15:45
Panel discussion
